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Abstract Connexin (Cx) proteins localized to neuronal
and glial syncytia provide the ultrastructural components for
intercellular communication via gap junctions. In this study,
a Cx45 reporter mouse model in which the Cx45 coding
sequence is substituted for enhanced green fluorescent
protein (eGFP) was used to characterize Cx45 expressing
neurones within adult mouse spinal cord. eGFP-immunore-
active (eGFP-IR) cells were localized at all rostro-caudal
levels to laminae I–III of the dorsal horn (DH), areas asso-
ciated with nociception. The neuronal rather than glial
phenotype of these cells in DH was confirmed by co-local-
isation of eGFP-IR with the neuronal marker NeuN. Further
immunohistochemical studies revealed that eGFP-IR inter-
neurones co-express the calcium-binding protein calbindin,
and to a lesser extent calretinin. In contrast, eGFP-IR profiles
did not co-localize with either parvalbumin or GAD-67, both
of which are linked to inhibitory interneurones. Staining
with the primary afferent markers isolectin-B4 (IB4) and
calcitonin gene-related peptide revealed that eGFP-IR
somata within laminae I–III receive close appositions from
the former, presumed non-peptidergic nociceptive afferents
of peripheral origin. The presence of 5-HT terminals in close
apposition to eGFP-IR interneuronal somata suggests mod-
ulation via descending pathways. These data demonstrate
a highly localized expression of Cx45 in a population of
interneurones within the mouse superficial dorsal horn. The
implications of these data in the context of the putative role
of Cx45 and gap junctions in spinal somatosensory pro-
cessing and pain are discussed.
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Introduction
In the adult mammalian central nervous system (CNS) gap
junctions provide for rapid metabolic and electrical inter-
cellular communication between neurones and glia (Nagy
and Rash 2000). Gap junctions are composed of two hemi-
channels expressing homotypic, heterotypic or heteromeric
combinations of specific connexin (Cx) subunit proteins that
influence channel conductance and kinetics (Sohl and
Willecke 2003). Profiling studies in brain indicate that Cx
subtypes are differentially localized to glia and neurones
thus Cx36 and Cx45 are unambiguously present in neurones
(Condorelli et al. 1998; Maxeiner et al. 2003; Hombach et al.
2004) whereas Cx43 and Cx30 are widely present in astro-
cytes (Theis et al. 2005). The concept of functional com-
partmentalization has emerged whereby the expression
pattern of Cx proteins defines the strength of coupling
between different cell types, thereby establishing a neuron-
glial syncytium that supports behaviours such as synchro-
nized firing or propagation of calcium waves across
disparate neuronal populations (Dermietzel 1998). Under-
standing the identity and expression patterns of Cx proteins
is therefore a prerequisite to study the functional significance
of gap junctions in the mature CNS.
Few studies have described in detail the distribution of
gap junctions in adult rat spinal cord, but freeze-fracture
studies revealed an abundance of mixed electrical/chemical
synapses distributed across the grey matter of laminae
III–IX (Rash et al. 1996). Regarding specific Cx subtypes,
spinal cord expression profiles to date parallel those
reported for brain. Thus, neuronal gap junctions contain
Cx36 (Rash et al. 2000) or Cx47 (Teubner et al. 2001),
whilst Cx32 and Cx43 are associated principally with oli-
godendrocytes and astrocytes, respectively (Rash et al.
2000; Nagy and Rash 2000; Ochalski et al. 1997). More
recently, the use of LacZ reporter gene expression or tar-
geted Cx45 gene deletion in mice has revealed a strong
association of this Cx subtype with neurones that express
the protein marker NeuN (Sohl et al. 2005). Cx45 is highly
expressed in brain during embryogenesis and after birth,
thereafter levels decline such that Cx45 is more restricted,
e.g. to thalamus or hippocampal CA3 region and different
cortical layers (Maxeiner et al. 2003). To our knowledge, a
full characterisation of the distribution of any of the neu-
ronal Cx subtypes, including Cx45, throughout the murine
spinal cord has not been performed. Determining the
identity and distribution of the connexins in the dorsal horn
is of interest because recent data imply a role for gap
junctions localized to neurones or glia in rhythmic activity
manifest in rat dorsal horn circuitry in vitro (Asghar et al.
2005; Chapman et al. 2009) and gap junctions are impli-
cated in pain facilitation and inflammation-induced noci-
ceptive behaviours (Lan et al. 2007; Qin et al. 2006).
Determining the distribution of Cx proteins in the CNS
using traditional approaches of in situ hybridisation and
immunohistochemistry has provided variable results and
connexin-specific protocols required for both methods are
not readily amenable to dual labelling (Sohl et al. 2005). As
an alternative strategy, we have used a previously charac-
terized transgenic mouse mutant line that expresses green
fluorescent protein (GFP) in place of the Cx45 coding
sequence (Maxeiner et al. 2005) to reveal a discretely
localized population of Cx45 expressing cells within the
superficial layers of the spinal dorsal horn. Immunohisto-
chemistry was used to define the phenotype of neurones
expressing Cx45 and determine putative sources of
extrinsic innervation. The concentrated expression of these
cells within laminae I–III places them in a strategic posi-
tion to potentially influence the processing of somatosen-
sory afferent inputs, particularly those arising from
nociceptors.
Materials and methods
Animals
All procedures were carried out in accordance with the UK
Animals (Scientific Procedures) Act of 1986 and experi-
mental protocols were approved by the local Faculty of
Biological Sciences Ethics Committee. All experiments
utilized mice with a cell-directed deletion of Cx45 and a
concomitant activation of GFP (Theis et al. 2000), the
constructs of which have been outlined previously in detail
(Maxeiner et al. 2005). In summary, to allow for condi-
tional deletion of the Cx45 coding region on exon3 of the
Cx45 gene, exon3 was flanked by two loxP sites in intron2
and downstream of exon3, respectively. Upstream of the 50
prime loxP site, a frt sites flanked minigene harbouring the
neomycin resistance gene under the regulatory elements of
the phosphoglycerate kinase promoter (PGK-neo) has been
inserted to identify positive clones during ES-cell culture.
Downstream of the second loxP site, the immediate
upstream intronic sequence of the Cx45 gene has been
duplicated and the endogenous Kozak consensus motif
has been fused to the enhanced green fluorescent protein
(eGFP) coding DNA. Eventually, Cre-recombinase
expression under control of the nestin promoter will lead to
the recombination of both loxP sites and delete the Cx45
coding DNA by replacing it with eGFP, restricting eGFP
expression primarily to neurones as described previously
(Maxeiner et al. 2005). To avoid putative disturbances in
the expression of Cx45/eGFP by constitutive expression of
the neomycin resistance gene, all mice analysed were
devoid of PGK-neo minigene accomplished by previous
breedings to Flp-recombinase expressing mice.
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Cx45-eGFP immunohistochemistry
Adult mice (n = 6) were anaesthetised with pentobarbitone
(60 mg/kg, i.p.) and transcardially perfused with fixative
containing 4 % paraformaldehyde (PFA; in 0.1 M phos-
phate buffer, pH 7.4). The spinal cords were removed and
post-fixed in 4 % PFA overnight at 4 C. Transverse sec-
tions (50 lm) cut from the middle of the cervical, thoracic,
lumbar and sacral regions were cut on a vibrating micro-
tome (Leica, Milton Keynes, UK) and collected into
phosphate-buffered saline (PBS; pH 7.2). Sections were
permeabilised by the inclusion of 0.1 % Triton X-100
(Sigma, UK) in the primary antibody solution to GFP,
washed in PBS (3 9 10 min) and transferred to either
chicken or rabbit anti-GFP primary antibodies (1:1,000,
Invitrogen) for 12–36 h (4 C). Prior to secondary antibody
application, all sections were washed in PBS (3 9 10 min).
Anti-GFP was visualised using Alexa488-conjugated don-
key anti-chicken or rabbit (1:1,000, Invitrogen). Secondary
antibodies were applied for 2–3 h (4 C) and sections
washed in PBS before drying, mounting and cover slipping
using Vectashield (Vector Laboratories, Peterborough,
UK). As a procedural control, the primary antibodies were
replaced by PBS to ensure that the antiserum detected the
appropriate antigen and under these conditions no staining
occurred. Low- and high-power images were captured
using a Nikon (Surrey, UK) Eclipse E600 epifluorescence
microscope and AcQuis image capture software (Synop-
tics, Cambridge, UK). Corel Draw 13 was used to adjust
brightness, contrast, intensity and gamma, if appropriate.
Some images (Fig. 3) were inverted to aid visualisation of
co-localisation in black and white images.
Double immunolabelling protocol
Following incubation in anti-GFP antibodies and Alexa488-
conjugated secondary antibodies as described above, spinal
cord lumbar sections were washed in PBS (3 9 10 min)
and incubated in primary antibodies (in PBS/0.1 % Triton
X-100) for 12–36 h (4 C). Sections were washed in PBS
(3 9 10 min) prior to secondary antibody application.
Anti-GFP was visualised using Alexa488-conjugated don-
key anti-chicken or rabbit (1:1,000, Invitrogen) and all
other antigens were individually visualised using Alexa555-
conjugated to the appropriate species for 2–3 h (4 C).
Biotinylated IB4 (1:100) was visualised by incubating
sections for 1 h in Streptavidin Alexa555 (1:100, Invitro-
gen). Staining for glutamate decarboxylase (GAD)-67
involved section pre-treatment by incubating in 50 % eth-
anol (30 min) and then in 10 % donkey serum (30 min),
but with the avoidance of triton following the protocol of
Fong et al. (2005) who noted that detergent decreased
GAD-67 labelling in somata in the brainstem. Thereafter,
sections were incubated in primary antibody for 12–36 h
(4 C). GAD-67 was visualised using a two-stage process:
(1) sections were incubated in biotin anti-mouse (1:200,
Vector Laboratories) for 4 h (4 C), washed (3 9 10 min)
and incubated in ExtrAvidin peroxidase (EAP; 1:1,500,
Sigma) for 12 h (4 C); (2) following removal from EAP,
sections were washed (3 9 10 min each) and amplified
using a tyramide signal amplification (TSA) kit (Couma-
rin–tyramide solution (1:100 PBS) plus 1 % hydrogen
peroxide solution (Perkin Elmer LAS Inc., USA). Finally,
sections were washed in PBS (3 9 10 min), air-dried,
mounted and cover slipped using Vectashield for viewing
with a Nikon E600 image capture system equipped with
epifluorescence.
Immunohistochemistry for Cx45
2-month-old wild type mice (C57/BL6) were anaesthetised
with intraperitoneal pentobarbital solution (50 mg/Kg) and
transcardially perfused with 0.1M PBS, pH 7.4 followed
with 2 % PFA and 0.2 % picric acid in 0.1 M phosphate
buffer (PB), pH 7.4 for 15 min. Spinal cords were sectioned
at 30–50 lm as above. Sections were treated with pepsin
(0.2 mg/ml) in 2 M HCL at 37 C for 10 min followed by
3-, 10-min washes in PB (Vervaeke et al. 2010). Sections
were then permeabilised with the inclusion of 3 % Triton
X-100 (Sigma) in the primary antibody solution; polyclonal
rabbit anti-Cx45 (1:250, Invitrogen, cat 40-7000) for 36 h at
4 C before visualisation with Alexa555 conjugated donkey
anti-rabbit (1:1,000, Invitrogen) as above. As a procedural
control, the primary antibodies were replaced by PBS to
ensure that the antiserum detected the appropriate antigen
and under these conditions no staining occurred.
Antibody characterisation
Calbindin (CB)
Mouse anti-CB D-28k monoclonal antibody (Swant, Swit-
zerland; code no. 300, lot no. 07(F); form, lyophilised
concentrated supernatant with no preservatives, used at
1:5,000) was produced by hybridization of mouse myeloma
cells with spleen cells from mice immunized with CB
purified from chicken gut. The staining observed with this
antibody gave an identical staining pattern in the mouse
spinal cord compared with previous investigations using an
antibody from a different origin (Ruda et al. 1994) and did
not stain the brain of CB knockout mice (Swant Data sheet).
Calcitonin gene-related peptide (CGRP)
Chicken anti-CGRP antibody was raised against the
synthetic peptide sequence KDNFVPTNVGSEAF-NH2
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(Neuromics, code no. CH14100, used at 1:200). Staining of
spinal cord sections revealed patterns previously docu-
mented with this antibody (Gao et al. 2009) and is identical
to immunoreactivity observed with different antibodies to
CGRP (Neumann et al. 2008).
Choline acetyltransferase (ChAT)
Polyclonal goat anti-ChAT antibody was produced from
human placental enzyme (Millipore, code no. AB144P,
used at 1:500). Immunoblot analysis has identified anti-
body specificity in cholinergic neurones in the CNS in a
variety of species (Millipore data sheet) and stains brain-
stem and spinal cholinergic neurones in well established
patterns (Milligan et al. 2006).
Calretinin (CR)
Rabbit anti-CR polyclonal antibody (Swant, Switzerland;
code no. 7699/3H, lot no. 18299; form, lyophilised anti-
serum, used at 1:5,000) was produced against human
recombinant CR. Antibody specificity was evaluated by
Biotin-Avidin labelling of fixed brain preparations and by
immunoenzymatic labelling of immunoblots (Swant data
sheet; Schwaller et al. 1993) and does not stain the brain of
CR knockout mice (Swant data sheet).
Cx45
Rabbit anti-Cx45 is raised against a synthetic peptide
corresponding to the c-terminal region of protein (Invitro-
gen code no. 40-7000, used at 1:250). The manufacturer
indicates that it specifically detects Cx45 in mouse brain
homogenates in western blots and stains expected cell
types in retina and mouse brain. Staining was comparable
to expression as indicated in Fig. 1 in this study.
GAD-67
Mouse anti-GAD67 monoclonal antibody (Chemicon,
MAB5406; Clone 1G10.2, used at 1:1,000) was produced
against recombinant GAD-67 fusion protein. The GAD-67
antibody reacts with the 67 kDa isoform of GAD-67 of rat,
mouse, and human origins, and there is no detectable cross
reactivity with GAD-65 by western blotting of rat brain
lysate (Chemicon data sheet for MAB5406; Fong et al.
2005).
Glial fibrillary acidic protein (GFAP)
Mouse monoclonal anti-GFAP antibody was produced by
hybridisation of Sp2/0 myeloma cells with splenocytes
from Balb/c mice immunised with purified human GFAP
(Biomol, code no. BML-GA1170; clone EB4). The anti-
body recognises GFAP in a wide range of species (Biomol
data sheet) and staining displays classic morphology and
distribution of fibrillary astrocytes.
GFP
According to the manufacturer, both rabbit (Invitrogen,
A11122) and chicken (Invitrogen, A10262) anti-GFP
antibodies are suited for detection of native GFP, GFP
variants, and GFP fusion proteins by western blot and
immunohistochemistry analysis using transgenic mice
expressing the GFP gene product. Labelling was only
detected in cells that expressed GFP and no staining was
observed in sections derived from wild-type mice.
5-Hydroxytryptamine (5-HT)
Rabbit polyclonal anti-5-HT antibody was raised against
5-HT coupled to bovine serum albumin with PFA (used at
dilution of 1:1,000). The pattern of staining observed
matches that observed with other 5-HT antibodies in spinal
cord terminals and brainstem raphe neurones (Izzo et al.
1993).
IB4
Isolectin GS-IB4 from Griffonia simplicifolia conjugated
to Alexa568 (Invitrogen, I21412) was used (1:100) to label
non-peptidergic nociceptive afferents (Snider and McMa-
hon 1998).
Mu opioid receptor (MOR)
Monoclonal rabbit anti-MOR antibody was raised against a
synthetic peptide corresponding to residues on the human
MOR (Abcam, code no. AB51140, diluted to 1,000). The
MOR antibody recognised a single band of approxi-
mately 52 kDa on immunoblots from human brain lysate
(Abcam data sheet). Staining was comparable to that
observed using different antibodies to the receptor
(Arvidsson et al. 1995).
Neuronal nuclei (NeuN)
Monoclonal mouse anti-NeuN (used at 1:1,000) was raised
against purified cell nuclei from mouse brain (Chemicon,
code no. MAB377; Clone A60). Immunohistochemistry
and immunoblots in a variety of CNS tissues revealed
detectable antigen only in nerve cells (Mullen et al. 1992).
The immunohistochemical staining is primarily localized
to the nucleus of the neurones, with lighter staining in
proliferative zones (Mullen et al. 1992). The few cell types
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not reactive with MAB377 include Purkinje, mitral and
photoreceptor cells.
Neurokinin-1-receptor (NK1R)
Polyclonal guinea pig anti-NK1R antibody was raised
against a synthetic peptide corresponding to the C-terminal
sequence (KTMTESSSFYSNMLA; amino acid residues
393–407) of the NK1R (Biomol, code no. BML-NA4200,
used at 1:500). This antibody has been characterised
extensively in rat (Vigna et al. 1994).
Nitric oxide synthase (nNOS)
Polyclonal rabbit anti-nNOS was raised against a synthetic
peptide corresponding to aa1414–1434 of human brain
NOS (NOS1; Biomol, code no. BML-SA227-0025, used at
1:1,000). This antibody specifically recognizes human,
Fig. 1 Regional expression of
Cx45-eGFP is consistent with in
situ hybridisation, reporter
expression in another transgenic
mouse line and protein
localisation. a, c, f eGFP-IR
from the Cx45-eGFP mouse.
b, d In situ hybridisation images
for Cx45, taken from the Allen
Brain Atlas. e, g Images of
expression in a Cx45 BAC
reporter mouse taken from the
Gensat project. High levels of
expression are evident in
neurones in the thalamus (a, b),
ependymal cells surrounding the
spinal cord central canal
(c–e) and in layers I–III in the
dorsal horn (f, g). Closed head
arrows indicate neurones whilst
open head arrows blood vessels
apparent due to smooth muscle
labelling. Immunoreactivity for
Cx45 can also be detected in the
ependymal cell layer (h), dorsal
horn (i) and in blood vessels (j).
b, e, g Inverted from original
images to correspond with those
shown here. rtn reticular
thalamic nucleus. Colour
images are available online
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mouse and rat nNOS (Biomol data sheet). Antibody
staining in mouse spinal cord reveals identical patterns to
those previously documented (Maihofner et al. 2000; Ma
and Eisenach 2007).
Oxytocin (OT)
Polyclonal rabbit anti-OT was raised against the amino
acid sequence CYIQNCPLG, corresponding to N-terminal
amino acids 20–28 of OT (Abcam, code no. AB11143,
used at 1:10,000). According to the manufacturer this
antibody blocks completely with OT peptide. Staining with
this antibody revealed a similar pattern of distribution to
previous investigations in the mouse spinal cord and a lack
of staining was observed in knockout mice lacking OT
(Robinson et al. 2002).
Protein kinase C (PKC)c
Polyclonal rabbit anti-PKCc was raised against a peptide
mapping the c-terminus of PKCc of mouse origin (Santa
Cruz Biotech, sc-211, used at 1:1,000). Staining with this
antibody gave an identical pattern of distribution in the
mouse spinal cord to previous reports (Malmberg et al.
1997).
Parvalbumin (PV)
Monoclonal mouse anti-PV was produced by hybridization
of mouse myeloma cells with spleen cells taken from mice
immunized with PV purified from carp muscles (Swant,
Switzerland; code no. 235, lot no. 10-11(F); form, lyoph-
ilised ascites, used at 1:5,000). Antibody specificity was
evaluated by immunoenzymatic labelling of immunoblots
and radioimmunoassay (Swant data sheet); (Celio et al.
1988). Additionally, immunolabelling using this antibody
is absent in PV knockout mice (Schwaller et al. 1999).
Tyrosine hydroxylase (TH)
Polyclonal sheep anti-TH was raised against native rat TH
purified from pheochromocytoma (Novus Biologicals, code
no. NB300-110; Clone LNC1, used at 1:1,000). Staining
with this antibody was identical to that observed in mouse
spinal cord using an antibody from a different origin
(Brumovsky et al. 2006).
Confocal microscopy and 3D reconstruction
Mounted sections were viewed on a confocal laser scan-
ning fluorescence microscope equipped with both argon
(kex = 488 nm) and He-Ne (kex = 543 nm) lasers that are
able to visualize optical sections through a 409 Fluor oil
immersion objective (numerical aperture 1.3). Confocal
images were captured as single slices or stacks and images
analysed using ReconstructTM software (Fiala 2005). Serial
images were imported into ReconstructTM and calibrated
using a scale bar. A 3D model of Cx45-eGFP cell bodies
could be generated by outlining the area of the cell somata
within each serial section image. Only close appositions to
Cx45-eGFP cell bodies were quantified since there is only
sparse dendritic staining for eGFP. To be considered as a
close apposition, the labelled presynaptic fibre was
required to be directly adjacent to the GFP neurone in the
same plane of focus, determined through confocal
microscopy and rotation of Z-stack images of apparent
contact point.
Data and statistical analyses
Cell counts were calculated from the whole dorsal horn
region of 10 representative sections from a minimum of 3
animals and contact density of potential terminal apposi-
tions were calculated from a minimum of 15 whole cells
from each animal. Data are expressed as mean ± SEM
where N represents the total number of cells and n repre-
sents the number of animals.
Results
Regional Cx45-eGFP expression in the CNS correlates
to in situ hybridisation
To determine if regional expression of eGFP in the Cx45
mice was consistent with Cx45 gene expression, we
compared eGFP immunohistochemistry with expression
reported by the Allen Brain Atlas (http://www.brain-map.
org/) in the brain (Image Series ID:77887876) as well as
the spinal cord (Image series ID = 100009459). The
expression studies reveal highest levels in the brain in the
thalamic relay nuclei, whilst the reticular thalamic nucleus
is devoid of labelling (Fig. 1b). This pattern is repeated in
Cx45-eGFP mice, where eGFP immunoreactivity is strong
in thalamic relay neurones but absent from the reticular
nucleus (Fig. 1a). In the spinal cord Cx45-eGFP was
apparent in the ependymal cells lining the central canal
(Fig. 1c) and this is paralleled by the expression levels
detected Allen Brain Atlas spinal cord (Fig. 1d). We further
compared expression in this transgenic mouse to that
observed in a reporter mouse made by the Gensat project
(Gensat 2011) using a BAC vector to control expression of
Cx45 (http://www.gensat.org/imagenavigator.jsp?imageID
=80609). Expression was comparable, localised predomi-
nantly to the ependymal layer of the central canal (Fig. 1e)
and the dorsal horn (Fig. 1f, g). In addition, the Gensat
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mouse revealed the expected labelling of blood vessel
smooth muscle (Fig. 1e, g). This is not observed in the
eGFP mouse as the deletion of Cx45 and hence expression
of GFP is directed only to neurones since eGFP-positive
cells co-labelled with NeuN but not GFAP (see below). We
also compared expression with labelling for Cx45 protein
and found concentrated immunoreactive spots, presumably
gap junction proteins, in the ependymal cell layer (Fig. 1h),
dorsal horn (Fig. 1i) and in blood vessels (Fig. 1j). Thus,
the reporter expression pattern in neurones in the mouse
used in this study was similar to that of another transgenic
mouse, to expression revealed by in situ hybridisation and
to the localisation of immunoreactivity.
Cx45-eGFP cells within the spinal cord dorsal horn are
neuronal
In addition to the ependymal cell layer, GFP-immunohis-
tochemistry to reveal the distribution of Cx45-eGFP in the
spinal cord indicated a discrete localisation to laminae I–III
of the dorsal horn (Fig. 2a). The highest concentration of
Cx45-eGFP cells was in lamina II encompassing both the
inner and outer layers. Cx45-eGFP cells were also
observed in lamina III, with most cells located near the
laminae II–III border. Fewer Cx45-eGFP cells were found
scattered across lamina I. No Cx45-eGFP cells were
observed in deeper laminae of the dorsal horn or within the
Fig. 2 Distribution of Cx45-eGFP cells is mainly concentrated
within neurones localized to laminae I–III of the cervical, thoracic,
lumbar and sacral DH. a Confocal scan of the lumbar spinal DH
showing a discrete band of GFP-IR cells lying predominantly within
laminae II–III. High power magnification of Cx45-eGFP cells present
in the lumbar DH (LDH; b) and cervical DH (CDH; c). d–i Confocal
tiled scan shows Cx45-eGFP cells co-localize with the neuronal
marker NeuN (f) but not with the glial marker GFAP (i) within
laminae I–III. Cx45-eGFP cells, black arrows with white borders;
NeuN and GFAP, white arrows. The third tile of each row shows a
merged representation; GFP-IR in cells was co-localized with NeuN,
grey arrows. Dashed lines represent the borders of lamina II
Brain Struct Funct (2013) 218:751–765 757
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ventral horn. Abundant Cx45-eGFP-immunoreactive
(eGFP-IR) could be found within the lumbar (Fig. 2b) and
thoracic regions of the spinal cord, although numerous
Cx45-eGFP cells were observed at all rostro-caudal levels
including cervical (Fig. 2c) and sacral regions. 3D recon-
struction of 90 Cx45-eGFP cells revealed a mean somatic
surface area of 45.9 ± 7.5 lm2 (n = 6). Dual-immunola-
belling of Cx45-eGFP with either NeuN or GFAP revealed
a strong association with the former. Whilst the number of
NeuN-IR cells was significantly higher than that of Cx45-
eGFP cells, all eGFP-IR was co-localized with NeuN
within laminae I–III (n = 3; Fig. 2d–f). In contrast to this,
whilst GFAP itself was abundantly expressed within spinal
grey matter, there was no apparent co-localisation with
Cx45-eGFP-IR profiles (n = 3; Fig. 2g–i).
Cx45-eGFP cells contain calcium-binding proteins
To probe further the phenotype of the Cx45-eGFP cells, we
performed dual immunolabelling of GFP with the calcium-
binding proteins (CBPs), CB, CR and PV as well as the
GABAergic marker GAD-67. All of the antigens investi-
gated revealed a wide distribution of cells containing CB,
CR, PV and GAD-67 throughout the dorsal horn and in
significantly higher numbers than Cx45-eGFP cells
(Fig. 3), in accordance with those published in the atlas of
the mouse spinal cord (Watson et al. 2009). Immunoreac-
tivity for the CBPs could be found throughout the spinal
cord, with a higher percentage of ventral horn neurones
staining for PV than CB or CR. In the dorsal horn, pro-
nounced CB and CR immunoreactivity was observed
within laminae I–II (Fig. 3b, e), whilst PV (Fig. 3h)
intensely stains the inner part of lamina II. Of the Cx45-
eGFP cells observed within laminae I–III (Fig. 3a, d, g, j),
93.5 ± 0.6 % were immunoreactive for CB (mean number
of cells taken from 10 sections: 17 ± 1 GFP cells, and
16 ± 1 CB containing cells; N = 405 of 433, n = 3;
Fig. 3c) and, to a lesser extent, 26.76 ± 1.2 % were
immunoreactive for CR (mean number of cells from 10
sections: 19 ± 1 GFP cells, and 7 ± 1 CR containing cells;
N = 110 of 411, n = 3; Fig. 3f). PV or GAD-67 contain-
ing cells were distinct from Cx45-eGFP cells at all levels of
the dorsal horn (n = 3, Fig. 3i, l).
Cx45-eGFP cells are putatively innervated by
non-peptidergic sensory afferents and descending
monoaminergic fibres
To determine putative sources of afferent innervation for
Cx45-eGFP cells, immunolabelling for both IB4 (a non-
peptidergic fibre marker) and CGRP (a peptidergic fibre
marker) was performed. Cx45-eGFP cells within laminae
I–II (Fig. 4a, c) were surrounded by IB4-positive fibres and
those in lamina III received close appositions from IB4-
positive fibres (Fig. 4b, d, e). 3D reconstructed models
permitted measurements of putative contact density of IB4-
positive fibres onto Cx45-eGFP cell somata (Fig. 4f, g).
From 45 Cx45-eGFP cells analysed, the average putative
contact density was calculated as 23.6 ± 2.4 appositions
per 100 lm2. Immunolabelling for CGRP revealed wide-
spread projections of presumed peptidergic sensory neu-
rones predominantly within lamina I and the outer layer of
lamina II (Fig. 4i). However, in contrast to IB4, Cx45-
eGFP cells were devoid of CGRP-positive close apposi-
tions (Fig. 4j).
Another major extrinsic source of innervation to the
dorsal horn is via descending 5-HT pathways. Labelling for
this monoamine was widespread throughout the dorsal horn
(Fig. 5b, e) and, more specifically, within laminae I–II in
the region of Cx45-eGFP cells. 5-HT terminals made close
appositions to Cx45-eGFP cell somata (Fig. 5c, f). Using
3D reconstructed models from 45 Cx45-eGFP cells, the
contact density of putative 5-HT terminals onto Cx45-
eGFP somata was calculated as 15.8 ± 1.92 appositions
per 100 lm2 (n = 3; Fig. 5g–i).
Immunolabelling for either OT or TH confirmed their
presence in mouse dorsal horn. Both OT and TH fibres
displayed a widespread distribution within the dorsal horn,
terminating within laminae I and II and some OT fibres
were found in lamina X. However, no clear association
with Cx45-eGFP cells was established in this study.
Cx45-eGFP-IR cells do not contain nNOS, ChAT,
NK1R, MOR and PKCc
To characterise the Cx45-eGFP-IR cells further, double
immunolabelling was performed with other cell markers
for identified dorsal horn populations such as nNOS,
ChAT, NK1R, MOR and PKCc (data not shown). Cells
immuno-positive for nNOS could be observed throughout
the superficial and deep dorsal horn but these were not
Cx45-eGFP-IR cells. ChAT-immunoreactivity could be
observed within the deep dorsal horn and ventral horn, but
did not overlap with Cx45-eGFP-IR. Numerous NK1R
immunoreactive cells were observed within laminae I and
III/IV, but those in lamina III did not co-localize with
Cx45-eGFP-IR. The distribution of MOR and PKCc
staining was mainly concentrated within the superficial
dorsal horn and also did not overlap with Cx45-eGFP-IR.
Discussion
In this study, we have demonstrated using Cx45-eGFP
transgenic mice that Cx45-eGFP cells are distributed along
the rostrocaudal extent of the spinal cord with expression
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mainly restricted to the grey matter of dorsal laminae I–III.
Cx45-eGFP cells were identified as neuronal on the basis
of co-localisation with NeuN and confined to a population
of interneurones that expressed CB, and to a lesser extent,
CR. No association was established between Cx45-eGFP
cells and interneurones containing either PV or GAD-67.
Fig. 3 Cx45-eGFP cells co-localize with the CBPs CB and CR.
a–f Cx45-eGFP cells show co-localisation with CB (c) and CR (f).
g–l No co-localisation is observed with PV, or with GAD-67. Cx45-
eGFP cells, closed head black arrows; cells containing CB, CR, PV or
GAD-67, white arrows; cells displaying co-localisation, open head
black arrows
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However, Cx45-eGFP somata were in close apposition to
IB4-positive fibres implying a non-peptidergic nociceptive
afferent source of peripheral innervation (Snider and
McMahon 1998). In addition, Cx45-eGFP cells were in
close proximity to 5-HT-containing fibres and may there-
fore receive some level of monoaminergic descending
neuromodulatory input.
Technical considerations—the Cx45-eGFP reporter
mouse model
Localisation of Cx45 protein has been difficult to obtain
due to low levels of Cx45 protein and lack of specific
antibodies, leading to the study of Cx45 expression using
mouse models in which the Cx45 gene has been replaced
by that for reporter molecules in the olivo-cerebellar sys-
tem (Van Der Giessen et al. 2006) and the retina (Maxeiner
et al. 2005; Schubert et al. 2005; Dedek et al. 2009).
Indeed, cells that express Cx45 as shown by reporter
molecules also reveal coupling in retinal neurones typical
of gap junctions and this coupling is disrupted when Cx45
is deleted (Maxeiner et al. 2005; Dedek et al. 2009), their
Fig. 4e), indicating that reporter expression correlates with
Cx45 gap junction protein presence. Such correlation of
eGFP expression with Cx45 in the reporter mouse in this
study appears to continue in the brain and spinal cord with
the observation that mRNA encoding Cx45 and eGFP are
present in the thalamic relay neurones and spinal cord
ependymal cells (Fig. 1). It cannot be guaranteed that
100 % of cells that express Cx45 can be visualised with
Fig. 4 a, b IB4 staining is clearly observed within laminae I/II of the
DH and makes close appositions to both Cx45-eGFP cells within
laminae I/II and those in lamina III. c–e Confocal scan of
representative cells (from lamina III in a) demonstrate the density
of projections surrounding the Cx45-eGFP cells. f, g A reconstructed
model example in two orientations illustrating the density of
projections onto the cell soma and putative sites of contact.
h–j Staining with CGRP demonstrates that Cx45-eGFP cells do not
receive close appositions from CGRP-positive fibres. Colour images
are shown online
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eGFP, since it is possible that low levels of expression
cannot be visualised even after immunohistochemical
amplification. However, similar issues including differen-
tiation from background may also arise with low mRNA
levels in in situ hybridisation or low protein levels in
immunohistochemistry. Nevertheless, the eGFP reporter
mouse facilitates dual immunohistochemical labelling,
which is rarely possible under the stringent conditions
necessary to detect mRNA using in situ hybridisation. We
have therefore utilised this advantage to localise Cx45-
eGFP in the spinal cord and to examine the neurochemistry
of the eGFP expressing cells in the dorsal horn.
Cx45 expression in the spinal cord and dorsal horn
Significant numbers of Cx45-eGFP cells were distributed
rostrocaudally along the entire spinal cord in cervical,
thoracic, lumbar and sacral segments. Cx45-eGFP neuro-
nes predominantly lay within superficial dorsal horn, an
area crucial for nociceptive sensory processing. The high-
est concentration of Cx45-eGFP cells was in laminae II–III
with fewer cells scattered across lamina I. Cx45-eGFP cells
were absent from deeper laminae (IV–VI) which process
mainly low threshold non-noxious sensory afferent inputs
(Willis and Coggeshall 2004). A strong association of
Cx45-eGFP cells in the dorsal horn with the neuronal
marker NeuN but not the glial marker GFAP confirms
earlier data derived from Cx45-reporter mice, where Cx45
expression was unequivocally associated with neurones
rather than glia (Maxeiner et al. 2003). In contrast to pre-
vious immunocytochemical data for Cx45 and spinal cord
(Pastor et al. 1998), we did not observe significant levels of
Cx45-eGFP within white matter oligodendrocytes.
Co-localisation of Cx45-eGFP cells with CB and CR
Calcium-binding proteins such as CB, CR and PV are
abundant in rat spinal dorsal horn and display distinct
patterns of expression (Ren and Ruda 1994). In rat super-
ficial dorsal horn, CB-containing cells are distributed
across I–III but are especially concentrated within I/II
whilst PV-containing cells are concentrated within the
inner portion of lamina II as well as laminae III (Yoshida
et al. 1990). CR is expressed in neurones of the rat dorsal
horn, particularly those localized to laminae II, and more
intensely within laminae V and VI (Ren and Ruda 1994). In
this study, characterization of CBP expression profiles in
mouse dorsal horn revealed close similarities to rat as
previously documented (Sasaki et al. 2006), whereby CB
and CR expression was observed within laminae I–II,
whilst PV intensely stains the inner part of lamina II. A
high degree of co-localisation of Cx45-eGFP cells with CB
Fig. 5 Cx45-eGFP cells receive close appositions from 5-HT
positive terminals. Cx45-eGFP can be seen throughout laminae II–
III (a) and staining for putative 5HT terminals can also be observed
throughout the DH (b). d–f High powered magnification of box A in
c displayed two example Cx45-eGFP cells surrounded by a high
density of putatively 5-HT terminals. g–i A reconstructed 3D model
example illustrating the density of 5-HT projections surrounding the
cell soma and potential sites of contact. Colour images are shown
online
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and to a lesser extent with CR but not with PV was evident.
The presence of specific CBPs in distinct neuronal popu-
lations has prompted the suggestion that CBPs may define
specific subsets of interneurones (Antal et al. 1991). Thus,
CB is present in glutamatergic neurones whilst PV neuro-
nes may characterize a subpopulation of GABAergic in-
terneurones (Ren and Ruda 1994; Todd and Spike 1993;
Albuquerque et al. 1999). Based on detected CBP expres-
sion profiles, it may be inferred that Cx45-eGFP cells in the
mouse dorsal horn are not GABAergic and have an excit-
atory phenotype. This proposal is reinforced by the lack of
co-localisation of Cx45-eGFP cells with GAD-67, a
GABA-synthesizing enzyme that is expressed in GAB-
Aergic interneurones (Heinke et al. 2004).
In superficial dorsal horn, CB but not PV has been co-
localized with neuropeptides such as substance P or
enkephalin (Yoshida et al. 1990). Both these neuropeptides
operate through G-protein-coupled receptor signalling
mechanisms that can impact on intracellular calcium levels
and play key roles in nociceptive processing. CB is
reportedly present in projection neurones within lamina I
that could either be spinothalamic or spinomesencephalic
(Yoshida et al. 1990; Menetrey et al. 1992). However,
immunolabelling for the NK1R receptor, which is present
in neurones within lamina I that constitute part of the
spinothalamic tract (Al-Khater et al. 2008), revealed no co-
localisation with the Cx45-eGFP cells. Nevertheless, some
of the CB-containing cells in laminae II–III cannot be ruled
out as also projecting to these brain regions (Yoshida et al.
1990).
Cx45-eGFP cells putatively receive nociceptive
non-peptidergic sensory afferent inputs
Two populations of nociceptors that terminate within
superficial dorsal horn have been characterized and consist
of an IB4-positive non-peptidergic group that projects to
the inner layer of lamina II and a CGRP-positive pepti-
dergic group that projects more superficially to lamina I
and the outer layer of lamina II (Hunt and Mantyh 2001;
Snider and McMahon 1998). There is sparse data on the
identity of neurones second order to these groups of sen-
sory afferents, although it is known that peptidergic
afferents containing substance P innervate NK1R immu-
noreactive projection neurones in lamina I and those with
cell bodies in lamina III or IV (Naim et al. 1997; Todd
et al. 2002). In this study, widespread projections of non-
peptidergic, presumed nociceptive, IB4-positive afferents
were pre-dominantly localized to lamina I and the inner
layer of lamina II, with some fibres observed in lamina III.
As Cx45-eGFP cells were distributed across laminae I–III,
it was observed that all Cx45-eGFP cell bodies within
laminae I–II were closely apposed by IB4-positive
afferents and most of the Cx45-eGFP cells within lamina
III were also in close proximity to IB4-positive afferents.
No evidence was obtained for significant putative inner-
vation by the CGRP-positive peptidergic afferent group
onto Cx45-eGFP somata although due to the low level of
dendritic eGFP expression we cannot eliminate the possi-
bility of undetected dendritic innervation. Thus IB4 noci-
ceptors may provide a significant source of synaptic input
to Cx45-eGFP cells in the DH but this requires further
validation. Although both groups of nociceptors are phys-
iologically classified as polymodal, i.e. respond to both
mechanical and thermal stimuli it has been suggested that
IB4 fibres co-expressing the G-protein-coupled receptor
‘Mrgprd’ are selectively required for painful mechano-
sensation (Cavanaugh et al. 2009; Zylka et al. 2005). In rat
dorsal horn, IB4 afferents terminate centrally within
glomeruli (Gerke and Plenderleith 2004), typically synap-
sing within a complex of dendrites and axons surrounded
by glia that are believed to provide for pre- and postsyn-
aptic modulation of sensory inputs. Our data for mouse
dorsal horn are suggestive of putative contacts between IB4
afferents and Cx45-eGFP neuronal somata rather than
within glomeruli but additional electron microscopy will be
required to validate this finding and determine whether
synapses are present.
Cx45-eGFP cells did not co-localize with PKCc, a sig-
nalling molecule that has been demonstrated to contribute
towards the induction and maintenance of persistent pain
following injury. PKCc cells within lamina II in the mouse
receive predominantly myelinated afferent inputs (Neu-
mann et al. 2008). As Cx45-eGFP cells do not co-localize
PKCc, this finding complements the proposal that Cx45-
eGFP cells receive putative non-peptidergic inputs. Addi-
tionally, Cx45-eGFP cells did not co-localize with NK1R,
MOR, nNOS or ChAT. With the exception of ChAT, all
these markers are observed in cells found within either
laminae I and/or II and have been documented to be
involved with nociceptive processing. ChAT could be
observed within lamina III and X, and as cholinergic
neurones within lamina III have been shown to frequently
co-localize GABA (Spike et al. 1993) this finding ties in
with the observed lack of co-localization of GAD-67 with
Cx45-eGFP cells.
Cx45-eGFP cells are innervated by 5-HT-, but not
TH- or OT-immunopositive fibres
The superficial dorsal horn receives extrinsic innervation
from diverse supraspinal regions via serotoninergic, oxy-
tocinergic, catecholaminergic/dopaminergic descending
pathways (VanderHorst and Ulfhake 2006). Immunoreac-
tivity for OT in dorsal horn mainly originates from direct
paraventricular hypothalamic projections to the spinal cord
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(Condes-Lara et al. 2007) and in rat OT-immunoreactivity
is predominantly found within laminae I–II (Reiter et al.
1994). TH-immunoreactivity may be representative of
noradrenergic, adrenergic and/or dopaminergic fibres that
originate in the mesopontine tegmentum especially the
locus coeruleus and in the mouse dorsal horn TH-immu-
noreactivity is most concentrated within laminae II–III
(VanderHorst and Ulfhake 2006). In this study, no clear
relationship was established between Cx45-eGFP cells and
OT-IR or TH-IR terminals. On the other hand, close
appositions were detected between 5-HT terminals and
Cx45-eGFP cells in laminae I–II. Serotoninergic innerva-
tion within the spinal cord is widespread and many 5-HT-
IR profiles are found within the inner layer of lamina II
with fewer in laminae III/IV (Steinbusch 1981; Marlier
et al. 1991). These data are suggestive of innervation of
Cx45-eGFP cells via descending monoaminergic control
systems that have been described as either pro- or anti-
nociceptive depending on the class of 5-HT receptors
activated (Suzuki et al. 2004).
Functional significance of Cx45-eGFP cells in murine
dorsal horn nociceptive circuitry
The physiological significance of localization of Cx45
within the superficial dorsal horn or whether Cx45 is
assembled into functional gap junctions remains to be
resolved. In fact, Cx45 is competent to form heterotypic
channels with several other Cx proteins including neuronal
Cx36 (Li et al. 2008) and glial Cx43 (Rackauskas et al.
2007). Data from cell lines have demonstrated that Cx45
can form either homotypic (Cx45/Cx45) or heterotypic
(Cx45/Cx43) gap junctions that are highly sensitive to the
transjunctional voltage (Bukauskas et al. 2002). Previ-
ously, using immature rat dorsal horn in vitro, we dem-
onstrated a contribution of gap junctions associated with
either neurones or glia in rhythmic behaviour generated by
neuronal networks embedded within substantia gelatinosa
(Asghar et al. 2005; Chapman et al. 2009). Emerging data
reveal a potential contribution of gap junctions to chronic
pain states. For example, Cx37 increased in sciatic nerve
after injury and this change correlated with behavioural
hyperalgesia (Lin et al. 2002). Gap junction-coupled
networks may exacerbate neuropathic spreading pain
sensations (Spataro et al. 2004) and contribute to abnor-
mal nociceptive behaviours and hyperalgesia induced by
inflammation (Qin et al. 2006). In conclusion, it is pos-
sible that the dorsal horn expresses Cx protein subtypes
that, under certain conditions, are incorporated into func-
tional gap junctions operating within coupled neuronal-
glial networks relevant to somatosensory encoding and
nociception.
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